Magnetic Resonance Diffusion Characteristics of Histologically Defined Prostate Cancer in Humans
Overview
Authors
Affiliations
The contrast provided by diffusion-sensitive magnetic resonance offers the promise of improved tumor localization in organ-confined human prostate cancer (PCa). Diffusion tensor imaging (DTI) measurements of PCa were performed in vivo, in patients undergoing radical prostatectomy, and later, ex vivo, in the same patients' prostatectomy specimens. The imaging data were coregistered to histological sections of the prostatectomy specimens, thereby enabling unambiguous characterization of diffusion parameters in cancerous and benign tissues. Increased cellularity, and hence decreased luminal spaces, in peripheral zone PCa led to approximately 40% and 50% apparent diffusion policy (ADC) decrease compared with benign peripheral zone tissues in vivo and ex vivo, respectively. In contrast, no significant diffusion anisotropy differences were observed between the cancerous and noncancerous peripheral zone tissues. However, the dense fibromuscular tissues in prostate, such as stromal tissues in benign prostatic hyperplasia in central gland, exhibited high diffusion anisotropy. A tissue classification method is proposed to combine DTI and T2-weighted image contrasts that may provide improved specificity of PCa detection over T2-weighted imaging alone. PCa identified in volume rendered MR images qualitatively correlates well with histologically determined PCa foci.
Anderson C, Ntala C, Ozel A, Reuben R, Chen Y Int J Numer Method Biomed Eng. 2023; 39(11):e3758.
PMID: 37477174 PMC: 10909480. DOI: 10.1002/cnm.3758.
Rezaeijo S, Jafarpoor Nesheli S, Fatan Serj M, Tahmasebi Birgani M Quant Imaging Med Surg. 2022; 12(10):4786-4804.
PMID: 36185056 PMC: 9511435. DOI: 10.21037/qims-22-115.
Cipollari S, Jamshidi N, Du L, Sung K, Huang D, Margolis D Prostate. 2021; 81(9):521-529.
PMID: 33876838 PMC: 9014804. DOI: 10.1002/pros.24129.
Diffusion Is Directional: Innovative Diffusion Tensor Imaging to Improve Prostate Cancer Detection.
Shenhar C, Degani H, Ber Y, Baniel J, Tamir S, Benjaminov O Diagnostics (Basel). 2021; 11(3).
PMID: 33804783 PMC: 8003841. DOI: 10.3390/diagnostics11030563.
Bailey C, Bourne R, Siow B, Johnston E, Brizmohun Appayya M, Pye H NMR Biomed. 2019; 32(5):e4073.
PMID: 30779863 PMC: 6519204. DOI: 10.1002/nbm.4073.